Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • Predict360 Reviews & Ratings
    4.7 out of 5 stars 18 Ratings
    Company Website for Predict360
  • Haast Reviews & Ratings
    4.9 out of 5 stars 5 Ratings
    Company Website for Haast
  • Hyperproof Reviews & Ratings
    4.6 out of 5 stars 354 Ratings
    Company Website for Hyperproof
  • Qualio Reviews & Ratings
    4.4 out of 5 stars 919 Ratings
    Company Website for Qualio
  • Interfacing Integrated Management System (IMS) Reviews & Ratings
    4.6 out of 5 stars 66 Ratings
    Company Website for Interfacing Integrated Management System (IMS)
  • Sumsub Reviews & Ratings
    4.6 out of 5 stars 241 Ratings
    Company Website for Sumsub
  • Captain Compliance Reviews & Ratings
    4.6 out of 5 stars 400 Ratings
    Company Website for Captain Compliance
  • Jama Connect Reviews & Ratings
    4.3 out of 5 stars 416 Ratings
    Company Website for Jama Connect
  • MedTrainer Reviews & Ratings
    4.3 out of 5 stars 250 Ratings
    Company Website for MedTrainer
  • Skillcast Reviews & Ratings
    4.9 out of 5 stars 1,109 Ratings
    Company Website for Skillcast

What is Flinn?

Flinn functions as an AI-driven solution aimed at improving and simplifying the regulatory and quality management processes within the medical device (MedTech) industry. By enabling manufacturers to integrate artificial intelligence into complex and repetitive tasks like post-market surveillance, literature reviews, complaint handling, and safety database oversight, it substantially reduces the manual effort required and aids in maintaining compliance with regulations such as the EU Medical Device Regulation (MDR). The platform aggregates data from diverse sources, employs machine learning methods to detect patterns and assess potential risks, generates automated reports that align with regulatory requirements, and supports the rapid launch and management of high-quality products on a broader scale. As a result, organizations can achieve process efficiency improvements by as much as ten times, all while ensuring the auditability, transparency, and traceability of their compliance efforts. This cutting-edge approach not only optimizes operations but also encourages companies to prioritize innovation and quality in their offerings, ultimately contributing to a more robust and dynamic MedTech landscape. By harnessing these advanced capabilities, businesses can stay ahead in an ever-evolving regulatory environment.

What is CoVigilAI?

CoVigilAI represents a state-of-the-art innovation in the realm of medical literature monitoring, harnessing the power of artificial intelligence and advanced data analytics to proactively detect and manage adverse drug reactions, ensuring patient safety and compliance with regulatory requirements in real-time. This platform facilitates the efficient tracking of scientific and medical literature by retrieving data from prominent global databases such as PubMed and Embase, and it offers customizable search options that improve the pharmacovigilance literature review process. Furthermore, it conducts thorough evaluations of scientific articles and publications from various regional journals, guaranteeing an extensive oversight of both global and localized literature. With the implementation of sophisticated algorithms, the system categorizes Individual Case Safety Reports (ICSRs) into three distinct classifications: valid, potential, and invalid cases, while its automated key entity recognition feature proficiently pinpoints critical components such as patients, medications, adverse reactions, and pertinent medical events. This comprehensive strategy not only streamlines the monitoring procedure but also considerably boosts the precision and efficiency of drug safety evaluations, contributing to a safer healthcare environment. Ultimately, CoVigilAI serves as an indispensable tool for enhancing drug safety and fostering informed decision-making in the medical field.

Media

Media

Integrations Supported

Integrations Supported

Embase
PubMed

API Availability

API Availability

Pricing Information

Pricing not provided

Pricing Information

Pricing not provided

Supported Platforms

SaaS

Supported Platforms

SaaS

Customer Service / Support

Web-Based Support

Customer Service / Support

Standard Support
Web-Based Support

Training Options

Documentation Hub
Online Training

Training Options

Documentation Hub
Online Training
On-Site Training

Company Facts

Organization Name

Flinn

Date Founded

2022

Company Location

Austria

Company Website

www.flinn.ai/

Company Facts

Organization Name

CoVigilAI

Company Location

India

Company Website

covigilai.in/

Categories and Features

Categories and Features

AI Science

Not specified

Pharmacovigilance

Not specified

Popular Alternatives

Popular Alternatives

ViSU Reviews & Ratings

ViSU

DDi
Threat Detective Reviews & Ratings

Threat Detective

Threat Detective Ltd
Dialog Reviews & Ratings

Dialog

Clarivate